PMS-Ranitidine · DIN 02242453 · 150 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-04 — choose a marketed DIN from the same-category list.Discontinued July 4, 2025 · checked November 20, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-04 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-04 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
PMS-Ranitidine · DIN 02242453
Manufacturer: Pharmascience Inc.; listing date 2001-03-07
Health Canada: Cancelled post market since 2025-07-04 · brand PMS-RANITIDINE 150 MG · ATC A02BA02 RANITIDINE · form Tablet · route Oral · ingredients RANITIDINE (RANITIDINE HYDROCHLORIDE) 150 MG · company Pharmascience inc · schedule Prescription
PMS-Ranitidine: Formulary list price $0.12 per unit (the source does not state the unit; exact figure $0.1197). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242453)
Source record
DIN 02242453: PMS-Ranitidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000010; group id 697; item number 1722; lccId None; manufacturer id PMS
Source form: Tab; strength: 150mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.1197; ministry $0.1197
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242453
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66172
Interchangeable products
Apo-Ranitidine · DIN 00733059 · $0.1197
Co Ranitidine · DIN 02248570 · $0.1197
Jamp-Ranitidine · DIN 02463717 · $0.1197
Mar-Ranitidine · DIN 02443708 · $0.1197
Mint-Ranitidine · DIN 02526379 · $0.1197
Ran-Ranitidine · DIN 02336480 · $0.1197
Sandoz Ranitidine · DIN 02243229 · $0.1197
Teva-Ranitidine · DIN 00828564 · $0.1197
Zantac · DIN 02212331 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 4, 2025 — choose a marketed DIN from the same-category list.